Nanoscale Systems for Local Drug Delivery

Overview

Journal Nano Today

Specialty Biotechnology

Date 2020 Aug 25

PMID 32831899

Citations 20

Authors

Tianjiao Ji

Daniel S Kohane

Affiliations

Soon will be listed here.

Abstract

Many diseases and conditions affect a relatively localized area of the body. They can be treated either by direct deposition of drug in the target area, or by giving the drug systemically. Here we review nanoparticle-based approaches to achieving both. We highlight advantages and disadvantages that nanoscale solutions have for locally administered therapies, with emphasis on the former. We discuss strategies to enable systemically delivered nanoparticles to deliver their payloads at specific locations in the body, including triggering (local and remote) and targeting.

Citing Articles

Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment.

Wu X, Yuan F, Guo L, Gao D, Zheng W, Chen C BMC Cancer. 2025; 25(1):285.

PMID: 39966717 PMC: 11837698. DOI: 10.1186/s12885-025-13693-0.

Emerging nanoplatforms towards microenvironment-responsive glioma therapy.

Tripathy N, Sahoo L, Paikray S, Dilnawaz F Med Oncol. 2025; 42(2):46.

PMID: 39812745 DOI: 10.1007/s12032-024-02596-y.

The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers.

Sun R, Chen Y, Pei Y, Wang W, Zhu Z, Zheng Z Heliyon. 2024; 10(18):e38165.

PMID: 39364250 PMC: 11447355. DOI: 10.1016/j.heliyon.2024.e38165.

Advances on Delivery System of Active Ingredients of Dried Toad Skin and Toad Venom.

Zhang D, Zhai B, Sun J, Cheng J, Zhang X, Guo D Int J Nanomedicine. 2024; 19:7273-7305.

PMID: 39050871 PMC: 11268768. DOI: 10.2147/IJN.S469742.

Repair spinal cord injury with a versatile anti-oxidant and neural regenerative nanoplatform.

Zhou H, Li Z, Jing S, Wang B, Ye Z, Xiong W J Nanobiotechnology. 2024; 22(1):351.

PMID: 38902789 PMC: 11188197. DOI: 10.1186/s12951-024-02610-5.

References

Han H, Lee H, Kim K, Kim H . Effect of high intensity focused ultrasound (HIFU) in conjunction with a nanomedicines-microbubble complex for enhanced drug delivery. J Control Release. 2017; 266:75-86. DOI: 10.1016/j.jconrel.2017.09.022. View

Maeda H . The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 2013; 104(7):779-89. PMC: 7657157. DOI: 10.1111/cas.12152. View

Varde N, Pack D . Microspheres for controlled release drug delivery. Expert Opin Biol Ther. 2003; 4(1):35-51. DOI: 10.1517/14712598.4.1.35. View

Fernandes R, Smyth N, Muskens O, Nitti S, Heuer-Jungemann A, Ardern-Jones M . Interactions of skin with gold nanoparticles of different surface charge, shape, and functionality. Small. 2014; 11(6):713-21. DOI: 10.1002/smll.201401913. View

de Groot F, Damen E, Scheeren H . Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors. Curr Med Chem. 2001; 8(9):1093-122. DOI: 10.2174/0929867013372634. View

Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H . In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2018; 14(1):89-97. DOI: 10.1038/s41565-018-0319-4. View

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

Kong S, Zhang W, Lee J, Brammer K, Lal R, Karin M . Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett. 2010; 10(12):5088-92. DOI: 10.1021/nl1033733. View

Wadhwa A, Kandadai S, Tongpresert S, Obal D, Gebhard R . Ultrasound guidance for deep peripheral nerve blocks: a brief review. Anesthesiol Res Pract. 2011; 2011:262070. PMC: 3145343. DOI: 10.1155/2011/262070. View

10.

Li S, Zhang Y, Wang J, Zhao Y, Ji T, Zhao X . Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours. Nat Biomed Eng. 2019; 1(8):667-679. DOI: 10.1038/s41551-017-0115-8. View

11.

Ilinskaya A, Dobrovolskaia M . Nanoparticles and the blood coagulation system. Part II: safety concerns. Nanomedicine (Lond). 2013; 8(6):969-81. PMC: 3939602. DOI: 10.2217/nnm.13.49. View

12.

Perry J, Reuter K, Luft J, Pecot C, Zamboni W, DeSimone J . Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location. Nano Lett. 2017; 17(5):2879-2886. PMC: 5708115. DOI: 10.1021/acs.nanolett.7b00021. View

13.

Lee S, Hwang G, Kim T, Kwon S, Kim J, Koh K . On-Demand Drug Release from Gold Nanoturf for a Thermo- and Chemotherapeutic Esophageal Stent. ACS Nano. 2018; 12(7):6756-6766. DOI: 10.1021/acsnano.8b01921. View

14.

Ji T, Zhao Y, Ding Y, Nie G . Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications. Adv Mater. 2013; 25(26):3508-25. DOI: 10.1002/adma.201300299. View

15.

Liu Q, Wang W, Zhan C, Yang T, Kohane D . Enhanced Precision of Nanoparticle Phototargeting in Vivo at a Safe Irradiance. Nano Lett. 2016; 16(7):4516-20. DOI: 10.1021/acs.nanolett.6b01730. View

16.

Luo D, Hasan M, Shahid S, Khlebtsov B, Cattell M, Sukhorukov G . Gold Nanorod Mediated Chlorhexidine Microparticle Formation and Near-Infrared Light Induced Release. Langmuir. 2017; 33(32):7982-7993. DOI: 10.1021/acs.langmuir.7b01656. View

17.

Zhao T, Huang G, Li Y, Yang S, Ramezani S, Lin Z . A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery. Nat Biomed Eng. 2017; 1. PMC: 5617128. DOI: 10.1038/s41551-016-0006. View

18.

Yang X, Du X, Liu Y, Zhu Y, Liu Y, Li Y . Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy. Adv Mater. 2013; 26(6):931-6. DOI: 10.1002/adma.201303360. View

19.

Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A . Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006; 12(4):1317-24. DOI: 10.1158/1078-0432.CCR-05-1634. View

20.

Prabhakar U, Maeda H, Jain R, Sevick-Muraca E, Zamboni W, Farokhzad O . Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013; 73(8):2412-7. PMC: 3916009. DOI: 10.1158/0008-5472.CAN-12-4561. View